BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32765878)

  • 1. Prognostic factors and skeletal-related events in patients with bone metastasis from gastric cancer.
    Imura Y; Tateiwa D; Sugimoto N; Inoue A; Wakamatsu T; Outani H; Tanaka T; Tamiya H; Yagi T; Naka N; Okawa S; Tabuchi T; Takenaka S
    Mol Clin Oncol; 2020 Oct; 13(4):31. PubMed ID: 32765878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and prognostic factors in patients with esophageal cancer with bone metastasis.
    Imura Y; Yamamoto S; Wakamatsu T; Tanaka T; Tamiya H; Sugimura K; Miyata H; Ishihara R; Yano M; Naka N
    Oncol Lett; 2020 Jan; 19(1):717-724. PubMed ID: 31897187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal-related events and prognosis in urothelial cancer patients with bone metastasis.
    Tsuda Y; Nakagawa T; Shinoda Y; Kanatani A; Kawai T; Taguchi S; Yamada Y; Sawada R; Kume H; Homma Y; Tanaka S; Kawano H
    Int J Clin Oncol; 2017 Jun; 22(3):548-553. PubMed ID: 28044212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for skeletal-related events (SREs) and factors affecting SRE-free survival for nonsmall cell lung cancer patients with bone metastases.
    Ulas A; Bilici A; Durnali A; Tokluoglu S; Akinci S; Silay K; Oksuzoglu B; Alkis N
    Tumour Biol; 2016 Jan; 37(1):1131-40. PubMed ID: 26276360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Developing Skeletal-Related Events in Breast Cancer Patients With Bone Metastases Undergoing Treatment With Bone-Modifying Agents.
    Tanaka R; Yonemori K; Hirakawa A; Kinoshita F; Takahashi N; Hashimoto J; Kodaira M; Yamamoto H; Yunokawa M; Shimizu C; Fujimoto M; Fujiwara Y; Tamura K
    Oncologist; 2016 Apr; 21(4):508-13. PubMed ID: 26975863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal related events in patients with bone metastasis arising from non-small cell lung cancer.
    da Silva GT; Bergmann A; Thuler LCS
    Support Care Cancer; 2016 Feb; 24(2):731-736. PubMed ID: 26143039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone Metastases in Medullary Thyroid Carcinoma: High Morbidity and Poor Prognosis Associated With Osteolytic Morphology.
    Vogel T; Wendler J; Frank-Raue K; Kreissl MC; Spitzweg C; Fassnacht M; Raue F; Kroiss M
    J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32072159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of renal cell carcinoma with bone metastases: Experience from a large cancer centre.
    Ruatta F; Derosa L; Escudier B; Colomba E; Guida A; Baciarello G; Loriot Y; Fizazi K; Albiges L
    Eur J Cancer; 2019 Jan; 107():79-85. PubMed ID: 30551078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and survival outcomes of synchronous and metachronous brain metastases: a retrospective population-based study.
    Jiang K; Parker M; Materi J; Azad TD; Kamson DO; Kleinberg L; Ye X; Rincon-Torroella J; Bettegowda C
    Neurosurg Focus; 2023 Aug; 55(2):E3. PubMed ID: 37527669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and risk factors of bone metastasis and skeletal related events in patients with primary breast cancer in Japan.
    Yamashiro H; Takada M; Nakatani E; Imai S; Yamauchi A; Tsuyuki S; Matsutani Y; Sakata S; Wada Y; Okamura R; Harada T; Tanaka F; Moriguchi Y; Kato H; Higashide S; Kan N; Yoshibayashi H; Suwa H; Okino T; Nakayama I; Ichinose Y; Yamagami K; Hashimoto T; Inamoto T; Toi M
    Int J Clin Oncol; 2014 Oct; 19(5):852-62. PubMed ID: 24292334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examination of burden of skeletal-related events in patients naive to denosumab and intravenous bisphosphonate therapy in bone metastases from solid tumors population.
    Bhowmik D; Song X; Intorcia M; Gray S; Shi N
    Curr Med Res Opin; 2019 Mar; 35(3):513-523. PubMed ID: 30286662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and predictors of Bone Metastases (BM) and Skeletal-Related Events (SREs) in Small Cell Lung Cancer (SCLC): A Swiss patient cohort.
    Conen K; Hagmann R; Hess V; Zippelius A; Rothschild SI
    J Cancer; 2016; 7(14):2110-2116. PubMed ID: 27877227
    [No Abstract]   [Full Text] [Related]  

  • 13. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
    Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
    J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic characteristics, metastasis-free survival, and skeletal-related events in 628 patients with skeletal metastases in a tertiary orthopedic and trauma center.
    Herget G; Saravi B; Schwarzkopf E; Wigand M; Südkamp N; Schmal H; Uhl M; Lang G
    World J Surg Oncol; 2021 Feb; 19(1):62. PubMed ID: 33632256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in patients with skeletal-related events at non-small-cell lung cancer diagnosis.
    Tominaga H; Setoguchi T; Shimada H; Nagano S; Sasaki H; Ishidou Y; Sato M; Mizuno K; Inoue H; Komiya S
    Mol Clin Oncol; 2017 Nov; 7(5):897-902. PubMed ID: 29181185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical characteristics and prognosis of renal cell carcinoma patients with bone metastases].
    Zhai JP; Liu N; Wang H; Wang HD; Man LB
    Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(14):1068-1071. PubMed ID: 32294868
    [No Abstract]   [Full Text] [Related]  

  • 17. An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival.
    Mannavola F; Mandala M; Todisco A; Sileni VC; Palla M; Minisini AM; Pala L; Morgese F; Di Guardo L; Stucci LS; Guida M; Indini A; Quaglino P; Ferraresi V; Marconcini R; Tronconi MC; Rossi E; Nigro O; Occelli M; Cortellini A; Quadrini S; Palmieri G; Pigozzo J; Ascierto PA; Vitale MG; Strippoli S; Ferrucci PF; Berardi R; Randon G; Cardone P; Schinzari G; Silvestris F; Tucci M
    Front Oncol; 2020; 10():1652. PubMed ID: 33042809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Features and Risk Factors of Skeletal-Related Events in Genitourinary Cancer Patients with Bone Metastasis: A Retrospective Analysis of Prostate Cancer, Renal Cell Carcinoma, and Urothelial Carcinoma.
    Owari T; Miyake M; Nakai Y; Morizawa Y; Itami Y; Hori S; Anai S; Tanaka N; Fujimoto K
    Oncology; 2018; 95(3):170-178. PubMed ID: 29874673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, risk factors and prognostic characteristics of bone metastases and skeletal-related events (SREs) in breast cancer patients: A systematic review of the real world data.
    Zhang H; Zhu W; Biskup E; Yang W; Yang Z; Wang H; Qiu X; Zhang C; Hu G; Hu G
    J Bone Oncol; 2018 Jun; 11():38-50. PubMed ID: 29511626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome and prognostic factors in single brain metastases from small-cell lung cancer.
    Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hörner-Rieber J; König L; Kappes J; Thomas M; Unterberg A; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
    Strahlenther Onkol; 2018 Feb; 194(2):98-106. PubMed ID: 29085978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.